Determining the Cost of a Bleeding-Related Episode in Primary Adult Chronic Immune Thrombocytopenia (ITP) in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.559
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prevalence of Diagnosed Adult Immune Thrombocytopenia in the United Kingdom

Advances in Therapy
MedicinePharmacology
2011English

A United Kingdom Immune Thrombocytopenia (ITP) Forum Review of Practice: Thrombopoietin Receptor Agonists

British Journal of Haematology
Hematology
2016English

An Update on the Immunopathology of Immune Thrombocytopenia (ITP)

Pathology
Forensic MedicinePathology
2020English

Highly Fluctuating Thrombocytopenia Developing in a Patient With Immune Thrombocytopenia (ITP) While Administering Romiplostim

Internal Medicine
Internal MedicineMedicine
2012English

Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases

Case Reports in Hematology
2018English

Identification of Novel Biomarkers in Chronic Immune Thrombocytopenia (ITP) by Microarray-Based Serum Protein Profiling

British Journal of Haematology
Hematology
2015English

The Efficacy and Safety of Romiplostim in Adult Patients With Chronic Immune Thrombocytopenia

Therapeutic Advances in Hematology
Hematology
2012English

Bleeding-Related Episodes (BRE) in Patients With Immune Thrombocytopenia (ITP) Receiving Eltrombopag (EPAG) or Romiplostim (ROMI): Real World Evidence From 26 US Institutions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cardiovascular and Bleeding Outcomes in a Population‐based Cohort of Patients With Chronic Immune Thrombocytopenia

Journal of Thrombosis and Haemostasis
MedicineHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy